Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Brain, 2022
Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer’s type

Martino Adami P., Orellana A., García P. et al.

Olink Target 96NeurologyPatient StratificationCSF

Pulmonary Circulation, 2022
Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension

Arvidsson M., Ahmed A., Säleby J. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Cell, 2022
Multiple early factors anticipate post-acute COVID-19 sequelae

Su Y., Yuan D., Chen D. et al.

Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationPlasma

Frontiers in Immunology, 2022
Identification of Robust Protein Associations With COVID-19 Disease Based on Five Clinical Studies

Suhre K., Sarwath H., Engelke R. et al.

Olink Target 96Infectious DiseasesTechnical EvaluationPlasma

Aging, 2022
A catalogue of omics biological ageing clocks reveals substantial commonality and associations with disease risk

Macdonald-Dunlop E., Taba N., Klarić L. et al.

Olink Target 96Wider Bioinformatics StudiesData SciencePlasma

Environmental Research, 2022
Serum levels of perfluoroalkyl substances (PFAS) and body composition – A cross-sectional study in a middle-aged population

Lind P., Lind L., Salihovic S. et al.

Olink Target 96Metabolic DiseasesEnvironmental Health & ToxicologyPathophysiologyPlasma

European Journal of Heart Failure, 2022
Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction

Chandramouli C., Ting T., Tromp J. et al.

Olink Target 96CVDPathophysiologyPlasma

Atherosclerosis, 2022
Soluble CD40 receptor is a biomarker of the burden of carotid artery atherosclerosis in subjects at high cardiovascular risk

Leonetti S., Tricò D., Nesti L. et al.

Olink Target 96CVDPatient StratificationPlasma

Frontiers in Immunology, 2022
Short Chain Fatty Acids Taken at Time of Thrombectomy in Acute Ischemic Stroke Patients Are Independent of Stroke Severity But Associated With Inflammatory Markers and Worse Symptoms at Discharge

Henry N., Frank J., McLouth C. et al.

Olink Target 96CVDPatient StratificationPlasma

The Lancet Respiratory Medicine, 2022
Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis

Bowman W., Newton C., Linderholm A. et al.

Olink Explore 3072/384Respiratory DiseasesPatient StratificationPlasma

Rheumatology, 2022
Clinical features and immune-related protein patterns of anti-MDA5 positive clinically amyopathic dermatomyositis Dutch patients

Hensgens M., Delemarre E., Drylewicz J. et al.

Olink Target 96Respiratory DiseasesImmunological & Inflammatory DiseasesPatient StratificationSerum

British Journal of Cancer, 2022
Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer

Mukama T., Fortner R., Katzke V. et al.

OncologyPatient StratificationPlasma

eLife, 2022
Epigenetic scores for the circulating proteome as tools for disease prediction

Gadd D., Hillary R., McCartney D. et al.

Olink Target 96AgingWider Proteomics StudiesEpidemiologyPlasma

Biomedicines, 2022
Recent Developments in Clinical Plasma Proteomics—Applied to Cardiovascular Research

Palstrøm N., Matthiesen R., Rasmussen L. et al.

CVDReview/editorial

Annals of Allergy, Asthma & Immunology, 2022
Lower viral loads in subjects with rhinovirus-challenged allergy despite reduced innate immunity

Feng X., Lawrence M., Payne S. et al.

Olink Target 96Immunological & Inflammatory DiseasesInfectious DiseasesPathophysiologyNasal Fluid

Clinical Cardiology, 2022
Proteomic differences among patients with heart failure taking furosemide or torsemide

Cooper L., Bruce S., Psotka M. et al.

Olink Target 96CVDPathophysiologyPlasma

Journal of Allergy and Clinical Immunology, 2022
Altered leukocyte subsets and immune proteome indicate proinflammatory mechanisms in mastocytosis

Hermans M., Heeringa J., Swagemakers S. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum

Frontiers in Oncology, 2022
A Linear Discriminant Analysis Model Based on the Changes of 7 Proteins in Plasma Predicts Response to Anlotinib Therapy in Advanced Non-Small Cell Lung Cancer Patients

Xu F., Xu H., Wan Z. et al.

Olink Target 96OncologyPatient StratificationPlasma

International Journal of Molecular Sciences, 2022
IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis

Wang X., Kaiser H., Kvist-Hansen A. et al.

Olink Target 96CVDDermatological DiseasesPathophysiologyPlasma

European Journal of Heart Failure, 2022
Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failure

Ceelen D., Voors A., Tromp J. et al.

Olink Target 96CVDPathophysiologyPlasma

1945 publications